16 November 2021
Directa Plus plc
("Directa Plus" or the "Company")
Directorate Change
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce that CFO, Giorgio Bonfanti, 30, who joined the Company in May 2021 has been appointed to the Board of Directa Plus with immediate effect.
Before joining the Company, Giorgio was employed by the global accountancy network PwC since 2014, working out of their Milan office. His most recent role was as a Senior Manager in their Deals practice, which is focussed on assistance with stock exchange listings, due diligence, company valuations, business plans, financial restructuring and accounting audits.
Giorgio holds a Master of Science in Accounting, Finance and Control, from the University Bocconi, Milan and a Bachelor Degree in Business Management, with a specialisation in Finance, from the University Cattolica, Milan.
Commenting, Giulio Cesareo, Founder and CEO of Directa Plus said: "We are very pleased to welcome Giorgio to the Board at Directa Plus. He is a highly competent and driven young man who has already delivering significant value to the Company since his appointment in May."
For further information please visit http://www.directa-plus.com/ or contact:
|
Directa Plus plc |
+39 02 36714458 |
|
Giulio Cesareo, CEO Giorgio Bonfanti, CFO |
|
|
|
|
|
Cenkos Securities plc (Nominated Adviser and Joint Broker) |
+44 131 220 6939 |
|
Neil McDonald Adam Rae |
|
|
|
|
|
Singer Capital Markets (Joint Broker) |
+44 20 7496 3069 |
|
Rick Thompson Phil Davies |
|
|
|
|
|
Tavistock (Financial PR and IR) |
+44 20 7920 3150 |
|
Simon Hudson Heather Armstrong |
|
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product), textiles (based on our G+® products) and, more recently, lithium-sulphur batteries. In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products. All our products are hypoallergenic, non-toxic and sustainably produced.
In relation to the appointment of Mr Bonfanti, the Company confirms that there is no further information to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules for Companies save as disclosed below:
-ends-
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
